<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>The Association of CD8+ Cytotoxic T Cells and Granzyme B+ Lymphocytes with Immunosuppressive Factors, Tumor Stage and Prognosis in Cutaneous Melanoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="The Association of CD8+ Cytotoxic T Cells and Granzyme B+ Lymphocytes with Immunosuppressive Factors, Tumor Stage and Prognosis in Cutaneous Melanoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d63/9775436/45ecb2b73a94/biomedicines-10-03209-g001.jpg"/> </div> <div class="text-side"> <h1>The Association of CD8+ Cytotoxic T Cells and Granzyme B+ Lymphocytes with Immunosuppressive Factors, Tumor Stage and Prognosis in Cutaneous Melanoma.</h1> <p>Representative immunohistochemical stainings of CD8+ lymphocytes (positive staining shown in brown and counterstained nuclei in blue). Immunohistochemical stainings of CD8 in benign (A) and dysplastic nevi (B), in situ melanoma (C), superficial (Breslow’s depth &lt; 1 mm, (D)) and deep melanomas (Breslow’s depth &gt; 4 mm, (E)) and lymph node metastasis (F). The dashed line in (A,B) defines the epidermis in benign and dysplastic nevi, respectively, and the dashed line in (C) marks the tumor–stroma borderline in in situ melanoma. The asterisks in (D–F) indicates the stromal tumor compartment, and black arrows in (D) point to tumor cells. Scale bar is 50 μm in (A) (and applies across (A–C), which all have ×200 magnification) and 100 μm in (D) (which applies across (D–F), which have all the same ×100 magnification), respectively.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36551965/" target="_blank">36551965</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>